Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
C
Cerevel Therapeutics Holdings, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 11 months ago
Cerevel Therapeutics Holdings, Inc., a leading biopharmaceutical company based in the United States, is dedicated to advancing treatments for neuroscience-related disorders. Founded in 2018, the company has quickly established itself in the industry, focusing on innovative therapies for conditions such as schizophrenia, epilepsy, and Parkinson's disease.
With a strong emphasis on research and development, Cerevel Therapeutics is known for its unique approach to drug discovery, leveraging insights from neuroscience to create targeted therapies. The company has made significant strides in clinical trials, positioning itself as a key player in the neurology sector. Its commitment to addressing unmet medical needs has garnered attention, making Cerevel a notable name in the biopharmaceutical landscape.
53
DitchCarbon score
+11 vs industry average
Cerevel Therapeutics Holdings, Inc.’s score of 53 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cerevel Therapeutics Holdings, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Cerevel Therapeutics Holdings, Inc. yet.
Cerevel Therapeutics Holdings, Inc.'s reported carbon emissions
Cerevel Therapeutics Holdings, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation.
Cerevel's climate initiatives are influenced by AbbVie Inc., which has established various reduction targets and commitments. However, specific reduction targets for Cerevel itself have not been disclosed. The company does not appear to have its own climate pledge or specific initiatives listed under the Science Based Targets initiative (SBTi) or other climate frameworks.
As a subsidiary, Cerevel may align its sustainability efforts with AbbVie’s broader environmental strategies, which include commitments to reduce greenhouse gas emissions across Scope 1, 2, and 3. However, without specific data or targets from Cerevel, it is challenging to provide a detailed overview of their individual climate commitments or performance.
In summary, while Cerevel Therapeutics Holdings, Inc. is part of a larger corporate family with potential climate commitments, it currently lacks publicly available emissions data and specific reduction targets.
Assessing Cerevel Therapeutics Holdings, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Cerevel Therapeutics Holdings, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Cerevel Therapeutics Holdings, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Cerevel Therapeutics Holdings, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from AbbVie Inc.2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Cerevel Therapeutics Holdings, Inc. yet.
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more